About
Declan Doogan is a physician-executive, biotech investor, and drug-development veteran who previously led worldwide development at Pfizer and later held senior roles at Amarin and Portage Biotech. He is a co-founder of Juvenescence, a partner at Mediqventures, a director at Tenax Therapeutics, and CEO/Executive Chairman of Causeway Therapeutics. Public sources also show direct equity ownership in Tenax and named participation in biotech financings including Intensity Therapeutics and Causeway Therapeutics.
Areas of interest
longevityaging therapeuticsdrug developmentbiotechAI drug discoveryRNA therapeuticssynthetic biologyoncologyneurologyliver disease / metabolic diseasefibrotic diseaseophthalmologyregenerative medicineprecision medicine